Minnesota
July 14, 2022
ROCHESTER, Minn. — A study led by researchers from Mayo Clinic Comprehensive Cancer Center has found that the addition of brentuximab vedotin to standard chemotherapy[...]
November 14, 2012
November 13, 2012
November 12, 2012
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community